Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
02 mai 2024 08h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
Recursion to Participate in Upcoming Investor Conferences
01 mai 2024 08h01 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Altitude Lab Secures Small Business Administration Growth Fund Accelerator Grant to Launch Horizon, a Commercialization Partnering Program
30 avr. 2024 08h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, April 30, 2024 (GLOBE NEWSWIRE) -- Altitude Lab and the Small Business Administration (SBA) are pleased to announce Horizon, a commercialization program to connect startups to...
Recursion to Participate in Upcoming Investor Conference
02 avr. 2024 08h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, April 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Recursion Publishes Annual Environmental, Social and Governance Report
26 mars 2024 08h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 26, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today announced...
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
01 mars 2024 14h58 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, hosted its second annual Rare...
Recursion to Participate in Upcoming Investor Conferences
01 mars 2024 07h59 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, March 01, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its...
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2023 Financial Results
27 févr. 2024 16h05 HE
|
Recursion Pharmaceuticals
Multiple clinical programs from Recursion’s first generation platform are on track to read out Phase 2 data in H2 2024 and H1 2025 with additional second generation programs approaching IND in the...
Recursion to Host Public L(earnings) Call on February 27
20 févr. 2024 07h59 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
Altitude Lab Startups Raise Over $120M in Capital
24 janv. 2024 09h00 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Altitude Lab today announced that its incubating startups raised over $120M in early-stage funding since commencing operations in 2020. Altitude Lab...